AJ Medical announcement: Shareholder BioVeda holds 5.6% of the company's shares and plans to reduce its holdings by no more than 1,355,515 shares through centralized bidding and bulk trading, accounting for 1% of the total shares. The reduction period is from October 10, 2024 to January 10, 2025, and the reason for the reduction is self-funding arrangement. The reduction plan complies with relevant laws and regulations and will not cause a change in the company's control.
奥精医疗：股东BioVeda计划减持不超过1%股份
AJ Medical: Shareholder BioVeda plans to reduce its shareholding by no more than 1%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated